Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Deals
Baheal Partners with AstraZeneca for Commercial Rights to Onglyza
January 31, 2025
Company
EQRx Shifts Strategy Amid FDA Feedback on China-Sourced Data
January 31, 2025
R&D
Peking University Study Identifies Liver Cancer Immune Microenvironment Subtypes
January 31, 2025
Company
Drug
CDE Prioritizes Review for Jiedi Pharma’s Mitotane and Other Key Drugs
January 31, 2025
Company
Drug
CanSino Biologics’ Inhalable COVID-19 Vaccine Authorized in Morocco
January 31, 2025
Company
Drug
Luye Pharma’s Biosimilar LY06006/BA6101 Approved for Osteoporosis Treatment
January 31, 2025
Company
Drug
Lundbeck’s Eptinezumab Launches in Boao Lecheng for Migraine Treatment
January 31, 2025
Company
Deals
Novartis Partners with Alibaba Health to Enhance Patient Medication Accessibility
January 31, 2025
Company
Drug
RemeGen’s Telitacicept Set for Breakthrough Therapy Designation in Myasthenia Gravis
January 31, 2025
Company
Deals
Harbour BioMed and Moderna Ink Licensing Deal for Oncology Immunotherapies
January 31, 2025
Company
Drug
CStone’s PD-L1 Inhibitor Sugemalimab Achieves Primary Endpoint in Gastric Cancer Study
January 31, 2025
Company
Drug
BeiGene’s Brukinsa Receives Marketing Approval in Brazil
January 31, 2025
1
2
…
1,095
1,096
1,097
1,098
1,099
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
